| scholarly article | Q13442814 |
| P2093 | author name string | Wei Zhang | |
| Hong Li | |||
| Qin Zhang | |||
| Ting Wang | |||
| Ang Gao | |||
| Yang Ding | |||
| Yuting Liang | |||
| Yaojuan Lu | |||
| Longwei Qiao | |||
| Nannan Zhao | |||
| P2860 | cites work | Analysis of Cell-Free DNA in Maternal Blood in Screening For Aneuploidies: Updated Meta-Analysis. | Q30234867 |
| Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. | Q33767643 | ||
| Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics | Q34535626 | ||
| Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis | Q35552815 | ||
| A multifactorial relationship exists between total circulating cell-free DNA levels and maternal BMI | Q36205202 | ||
| Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA | Q36332125 | ||
| Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women | Q36354286 | ||
| First trimester fetal growth restriction and cardiovascular risk factors in school age children: population based cohort study | Q37513363 | ||
| A Forward Look At Noninvasive Prenatal Testing | Q38812774 | ||
| The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics | Q38821212 | ||
| Obesity and cell-free DNA "no calls": is there an optimal gestational age at time of sampling? | Q40353262 | ||
| Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies. | Q41566460 | ||
| Cherchez la femme: maternal incidental findings can explain discordant prenatal cell-free DNA sequencing results | Q47351507 | ||
| Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms | Q47423342 | ||
| Size distributions of maternal and fetal DNA in maternal plasma. | Q47432593 | ||
| Evaluation of extraction methods for methylated cell-free fetal DNA from maternal plasma | Q50052174 | ||
| The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. | Q54708648 | ||
| Size-tagged preferred ends in maternal plasma DNA shed light on the production mechanism and show utility in noninvasive prenatal testing. | Q55209454 | ||
| Maternal Plasma DNA Sequencing Reveals the Genome-Wide Genetic and Mutational Profile of the Fetus | Q56937251 | ||
| Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
| The future of DNA sequencing | Q59091736 | ||
| Enrichment of the fetal fraction in non-invasive prenatal screening reduces maternal background interference | Q59792872 | ||
| Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics | Q61847812 | ||
| Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for noninvasive prenatal testing | Q85218234 | ||
| Performance of screening for aneuploidies by cell-free DNA analysis of maternal blood in twin pregnancies | Q85719707 | ||
| Sequencing of Circulating Cell-free DNA during Pregnancy | Q90691273 | ||
| Classification of factors involved in nonreportable results of noninvasive prenatal testing (NIPT) and prediction of success rate of second NIPT | Q90755910 | ||
| P433 | issue | 7 | |
| P304 | page(s) | 4450-4459 | |
| P577 | publication date | 2019-07-15 | |
| P1433 | published in | American Journal of Translational Research | Q4744272 |
| P1476 | title | Sequencing of short cfDNA fragments in NIPT improves fetal fraction with higher maternal BMI and early gestational age | |
| P478 | volume | 11 |
Search more.